Table of Contents Table of Contents
Previous Page  766 / 812 Next Page
Information
Show Menu
Previous Page 766 / 812 Next Page
Page Background

S762

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

Introduction

Infertility is not only a medical condition and its

impact in mental health is well established. Although most couples

facing fertility problems and the demands of medical treatment

are able to adjust, some of them may show psychological difficul-

ties with clinical relevance, such as depression and anxiety. The

Mindfulness Based Program for Infertility (MBPI) is a group inter-

vention designed for infertile women and data from its efficacy

study revealed impact in depressive symptoms reduction as well

as in internal and external shame, entrapment and defeat. Based

on the MBPI, a mindfulness app targeting infertile patients was

developed – the MindfulSpot.

Aims

This study addresses the MindfulSpot development.

Methods

TheMindfulSpot is a prototypemobile app, which seeks

to offer the chance of practicing mindfulness in a comfortable and

accessibleway. This app covers informative audio andwritten texts.

The audio contents correspond tomindfulness formal practices and

suggestions for informal practice, making possible its use through-

out different moments of the day. Beyond the practices mentioned

above, users are invited to explore the informative menu, includ-

ing information on the impact that infertility may have in several

aspects of the patients’ lives.

Results

The efficacy of the MindfulSpot is still under analysis and

results are expected to be available soon.

Conclusions

The MindfulSpot was designed as a medium for

training mindfulness skills and it includes useful information

regarding specific aspects of the emotional impact of infertility.

Additionally to its independent use, it may also be used as a support

tool of the MBPI.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.2279

EV1295

Towards a gold standard for

internet-delivered programs in

behavioral and mental health

D. Richards

1 , 2 ,

, N .

Vigano

1 , D.D

. O’Callaghan

3 , E. O

’Brien

1 ,

J. Mooney

1 , C. B

onner

1

1

SilverCloud Health, Clinical Research & Innovation, Dublin, Ireland

2

Trinity College Dublin, School of Psychology, Dublin, Ireland

3

SilverCloud Health, Chief Security Officer, Dublin, Ireland

Corresponding author.

Introduction

Technological innovation has been pervasive and

has touched almost every aspect of modern life, including the deliv-

ery of behavioural and mental heath care. As telehealth expands,

internet interventions are particularly interesting as a medium of

delivering effective care. However, standards are required to help

informhealthcare policymakers, providers, clinicians and patients.

Objective

Move towards outlining a gold standard for internet-

delivered behavioural and mental health interventions.

Aims

Contribute and build upon existing standards and guide-

lines for the practice of telehealth, but to now extend these to

include internet-delivered interventions.

Methods

Drawing from research, experience and practice, the

authors propose a matrix for the evaluation of what might be

considered a gold standard for internet-delivered behavioural and

mental health interventions.

Results

Seven elements are proposed and considered aspects

of what would constitute a gold standard and they include,

the use of evidence-based and empirically supported content,

robust, engaging, secure and responsive technologies, shaped by

behavioural health subject matter experts, employ user-centred

design and development principles, have a focus on accountable

care-achieving clinical outcomes, have research and evaluation that

supports its effectiveness, and a well developed implementation

science and support.

Conclusion

The paper proposes some characteristics that could

compose a gold standard for internet-delivered interventions for

behavioural and mental health care. The contribution is neither

exhaustive nor conclusive, but offers an invitation to the discussion.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.2280

EV1296

mHealth in mental health: What do

the users think about it?

J.M. Sengelen

, I.C.

Banea

Centre Hospitalier de Rouffach, pôle 2/3, Rouffach, France

Corresponding author.

There is currently a major trend for e-health and the first men-

tal health applications for smartphones are now released. Patients

and health care professionals are still struggling to position them-

selves in relation to these new approaches. So, we wanted to know

more about the involvement of mental health users and their care

providers in mobile health (mHealth) technologies. We needed to

understand their expectations and their reluctances. For achieving

this purpose, we carried out an online survey for mental health

users (

n

= 108). It turns out that people who responded to this sur-

vey are well equipped with smartphones and are experienced in

using mobile apps. They expect from professionals an advisory role

in relation to e-health. The major interest lies in practical, concrete

applications and the main reluctance is about management, transit

and storage of data. It is necessary to involve mental health users

and health care professionals together in order to develop these

new tools. To achieve this, health care professionals must continue

to invest themselves in the use and understanding of m-Health

tools.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.2281

Treatment practice

EV1297

Drug-induced tardive dyskinesia: A

case report

I. Abida

, I. Baati , S. Omri , R. Sallemi , J. Masmoudi

CHU Hédi Chaker, Sfax, Tunisia

Corresponding author.

Introduction

Tardive dyskinesia (TD) is a serious medical condi-

tion that affects a significant proportion of patients treated with

antipsychotic agents.

Objective

To report a patient who developed tardive dyskinesia

after initiation of antipsychotic and antidepressant treatment.

Case report

Miss H. is 24-year-old Tunisianwomanwho had been

diagnosed with bipolar disorder 6 years ago. She received various

drugs: olanzapine, haloperidol, amisulpride, sertraline, paroxetine,

etc. On November 2013, she first complained of hand tremor and

then developed severe dystonia of the trunk and chorea. A series

of laboratory tests was performed after the onset of these invol-

untary movements. It included complete blood count, liver, renal,

and thyroid function tests, blood prolactin level, blood glucose

level, blood copper level and ceruloplasmin level. A brain MRI

was also performed. These examinations showed no specific find-

ings. The diagnosis of TD was presumed. The patient was first

treated with amisulpride, lorazepam, avlocardyl and piracetam

until May 2014. Then, amisulpride was substituted by olanzapine